Your browser doesn't support javascript.
loading
Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling.
Vemulapalli, Vidyasiri; Chylek, Lily A; Erickson, Alison; Pfeiffer, Anamarija; Gabriel, Khal-Hentz; LaRochelle, Jonathan; Subramanian, Kartik; Cao, Ruili; Stegmaier, Kimberley; Mohseni, Morvarid; LaMarche, Matthew J; Acker, Michael G; Sorger, Peter K; Gygi, Steven P; Blacklow, Stephen C.
Afiliação
  • Vemulapalli V; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.
  • Chylek LA; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States.
  • Erickson A; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.
  • Pfeiffer A; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Gabriel KH; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • LaRochelle J; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.
  • Subramanian K; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States.
  • Cao R; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.
  • Stegmaier K; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States.
  • Mohseni M; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.
  • LaMarche MJ; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.
  • Acker MG; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, United States.
  • Sorger PK; Novartis Institutes for Biomedical Research, Cambridge, United States.
  • Gygi SP; Novartis Institutes for Biomedical Research, Cambridge, United States.
  • Blacklow SC; Novartis Institutes for Biomedical Research, Cambridge, United States.
Elife ; 102021 03 23.
Article em En | MEDLINE | ID: mdl-33755016

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Proteína Tirosina Fosfatase não Receptora Tipo 11 / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Proteína Tirosina Fosfatase não Receptora Tipo 11 / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article